New to The Street Announces its Five Corporate Interviews, Airing Episode 591 on the Fox Business Network, Tonight Monday, August 26, 2024, at 10:30 PM PT
Acurx Pharmaceuticals, Inc. (ACXP)
Company Research
Source: GlobeNewswire
NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- FMW Media's New to The Street, a nationally broadcasted business TV show, announces episode 591, airing on the Fox Business Network tonight, Monday, August 26, 2024, at 10:30 PM PT. New to The Street's 591st TV episode line-up features the following five (5) Corporate interviews: 1). Biopharmaceutical - Acurx Pharmaceuticals, Inc.'s (NASDAQ: ACXP) ($ACXP) David Luci, President/CEO. 2). "Game Changers" segment interview with Iagon's (CRYPTO: IAG) ($IAG) Dr. Navjit Dhaliwal, CEO. 3). "Game Changers" segment interview with GreenLite Ventures, Inc.'s (OTC: GRNL) ($GRNL) (No Limit Technology Holdings, Inc.) Rafael Groswirt, CEO 4). Sustainable Solutions - The Sustainable Green Team, Ltd.'s (OTC: SGTM) ($SGTM) Tony Raynor, CEO and Founder. 5). "Sekur Privacy & Sekur Security – The Weekly Hack” segment with internet privacy expert Alain Ghiai, CEO, Sekur Private Data, Ltd. (OTCQB: SWISF) (CSE: SKUR) (FRA: GDT0) ($SWISF) (Sekur®).
Show less
Read more
Impact Snapshot
Event Time:
ACXP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ACXP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACXP alerts
High impacting Acurx Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ACXP
News
- Acurx Announces Additional Ibezapolstat Ph2b Results in CDI as well as Anthrax (B. anthracis) Susceptibility to ACX-375 AnaloguesPR Newswire
- Acurx Announces Results of Its Pioneering Research with Ibezapolstat in Collaboration with Leiden University Medical Center at the Premier International C. difficile SymposiumPR Newswire
- New to the Street Announces Its Five Corporate Interviews, Airing Episode 599 on the Fox Business Network, Tonight Monday, September 9, 2024, at 10:30 PM PT September 9, 2024 09:15 ETAccesswire
- ACURX PHARMACEUTICALS ANNOUNCES PARTICIPATION AT THE H.C. Wainwright 26th Annual Global Investment ConferencePR Newswire
- We're A Little Worried About Acurx Pharmaceuticals' (NASDAQ:ACXP) Cash Burn Rate [Yahoo! Finance]Yahoo! Finance
ACXP
Earnings
- 8/9/24 - Beat
ACXP
Analyst Actions
- 8/12/24 - HC Wainwright
ACXP
Sec Filings
- 8/9/24 - Form 8-K
- 8/8/24 - Form 10-Q
- ACXP's page on the SEC website